This study investigated the impact of sleep deprivation on the human circadian system. Plasma melatonin and cortisol, and leukocyte expression levels of 12 genes were examined over 48 h (sleep vs no sleep nights) in 12 young males (mean ± SD, 23 ± 5 yrs). During one night of total sleep deprivation BMAL1 expression was suppressed, the heat shock gene HSPA1B expression was induced, and the amplitude of the melatonin rhythm increased while other high-amplitude clock gene rhythms (e.g. PER1-3, REV-ERB) remained unaffected.
Introduction
In our modern 24/7 society, chronic partial sleep deprivation is becoming increasingly common. There is mounting evidence that long-term sleep deprivation has a severe impact on health and enhances vulnerability to both, infectious diseases and pathologies such as diabetes, obesity, or cancer (Lamont et al., 2007; Logan & Sarkar, 2012; Mullington et al., 2010) . Restricted sleep has been shown to significantly phase-delay the melatonin rhythm in humans, independent of bedtime (Burgess & Eastman, 2004; Burgess & Eastman, 2006) . The acute impact of sleep deprivation on the circadian system, however, has not been fully elucidated in humans. As the circadian system controls most aspects of our daily lives, including cyclic changes in physiology, behaviour, and metabolism (Hastings et al., 2003; Mohawk et al., 2012) , profiling of the central and peripheral clocks during sleep deprivation will be key to understanding the molecular basis of how these pathologies develop (Hastings et al., 2003; Kyriacou & Hastings, 2010; Lamont et al., 2007; Logan & Sarkar, 2012) .
In mammals, the core clock mechanism is based on a transcriptional-translational feedback loop involving the Period (PER) and Cryptochrome (CRY) genes as negative elements, the basic helix-loop-helix Per-Arnt-Sim (PAS) transcription factors CLOCK and BMAL1 as positive components (Hastings et al., 2003; Isojima et al., 2003) and a range of auxiliary loops for stabilisation (Albrecht, 2012; Isojima et al., 2003; Relogio et al., 2011) . While there are a number of reports on rhythmic expression of clock genes in human peripheral blood cell oscillators (Archer et al., 2008; Boivin et al., 2003; Fukuya et al., 2007; Kusanagi et al., 2008) , studies investigating changes in these rhythms upon sleep deprivation are fewer. A recent study provided some data on clock gene expression during sleep deprivation under light conditions compared to during sleep (Kavcic et al., 2011) . The authors found significant rhythmicity for BMAL1 expression under both conditions whereas rhythmicity in PER2 expression was strongly affected by sleep deprivation. The study, however, was limited by a small number of subjects (n = 7), a blood sampling interval of 4 h, and restriction to the analysis of two genes (PER2 and BMAL1). An earlier study in six subjects described comparable rhythms for PER1 and PER2 under sleep/wake and constant routine sleep deprivation conditions, and a more variable expression for BMAL1, with differences in peak times between the two conditions . Studies in mice showed that cryptochromes may be involved in the homeostatic regulation of sleep, and that changes in the expression of clock-related genes in the cerebral cortex during sleep deprivation are strain-dependent and parallel the electroencephalographic response (Wisor et al., 2002; Wisor et al., 2008) . Using microarrays, a recent study showed that the number of brain transcripts affected by sleep deprivation, including some circadian genes, could be reduced by adrenalectomy (Mongrain et al., 2010) .
Similarly, although melatonin and cortisol are two well-characterised central circadian clockcontrolled hormones, the effect of acute sleep deprivation on their rhythmicity (in terms of amplitude and timing) has provided conflicting results (Salin-Pascual et al., 1988; von Treuer et al., 1996; Zeitzer et al., 2007) . While one study observed increased melatonin levels after sleep deprivation, cortisol levels remained unchanged, and no information was given on the timing of the melatonin rhythm (Salin-Pascual et al., 1988) . Another study described opposite results, with elevated cortisol and unchanged melatonin levels on the sleep deprivation night (von Treuer et al., 1996) . A more recent study also reported elevated levels of melatonin during extended wakefulness (constant routine conditions) in young subjects, and an age-dependent difference in melatonin concentrations during sleep deprivation (Zeitzer et al., 2007) .
The current study aimed to assess the impact of one night of total sleep deprivation under strictly controlled laboratory conditions on markers of both the central circadian pacemaker, located in the suprachiasmatic nuclei (SCN) of the hypothalamus, and peripheral blood cell
oscillators. An in-depth characterisation of diurnal rhythms in expression levels of 11 clock genes (PER1-3, CRY1-2, BMAL1, CLOCK, DBP, DEC1, REV-ERB, RORA), a heat shock gene (HSPA1B) known to be involved in the oxidative stress response in peripheral leukocytes, and a comprehensive analysis of the circadian rhythms of plasma melatonin and cortisol was undertaken during a full 24 h sleep/wake cycle and a subsequent 24 h wake/wake cycle (i.e. a night of total sleep deprivation).
Materials and methods

Clinical study
Clinical sessions were conducted at the Surrey Clinical Research Centre (SCRC) at the
University of Surrey (UK). Ethical approval was obtained from the University Ethics
Committee and all procedures were conducted in accordance with the Declaration of Helsinki. The experimental protocol of the study conformed to international ethical standards (Portaluppi et al., 2010) .
A detailed description of the study protocol and the initial screening phase including eligibility criteria have been reported previously (Ackermann et al., 2012) . Briefly, study eligibility was determined by questionnaires, medical and physical assessment, and analysis of blood and urine samples. Exclusion criteria included, but were not limited to, smoking, the taking of prescription medication, abnormal blood haematology and testing positive for drugs of abuse. Healthy males (n = 15; mean age ± SD: 24 ± 5 yrs), participated in the study, with 6 consent was obtained and participants were allowed to withdraw at any time. All participant information was coded and held in strictest confidence according to the Data Protection Act (UK, 1998).
Participants were required to maintain a strict regular sleep-wake schedule for 7 days prior to entering the laboratory, confirmed by activity/light monitors (Actiwatch, CamNtech, Cambridge, UK), sleep logs and time-stamped voicemail, which aimed at stabilising the circadian clock and ensuring that participants were not sleep deprived. In addition, they were required to get at least 15 min of outdoor lighting within 90 min of waking each day.
Consumption of caffeine, alcohol and medication was prohibited for the final 3 days of this baseline period.
Participants entered the laboratory at 17:00 h on day 1 and remained there until 18.00 h on day 4. Overnight periods were spent in individual sleep laboratories, with the adaptation (night 1; N1) and baseline (night 2; N2) nights including a normal sleep period (23:00 -07:00 h), and total sleep deprivation on the third night (night 3; N3). Polysomnography monitoring occurred on nights 2 and 3 to confirm sleep on night 2 and wakefulness on night 3. Blood samples for gene expression and hormone analyses were collected into PAXgene RNA tubes (Qiagen, Crawley, UK) and lithium heparin tubes at hourly intervals for 48 hours (from 12:00 h on day 2 to 12:00 h on day 4) using an intravenous catheter and sampling through a portal in the wall on night 2 so that sleep was not disturbed. Subjects had a recovery sleep from 13:00 -18:00 h on day 4 before leaving the laboratory. Identical meals (breakfast, lunch, dinner, and snack) were eaten by all participants during the study according to UK dietary guidelines. Meals were identical in composition on each day of the study. A detailed scheme of the study protocol is shown in Figure 1 .
Sample analysis
Hormone assays
Radioimmunoassay analysis was performed on hourly plasma samples to determine melatonin and cortisol concentrations (Stockgrand Ltd., University of Surrey, UK) as described previously (Fraser et al., 1983; Sletten et al., 2009 ).
RNA isolation, reverse transcription and real-time polymerase chain reaction (qRT-PCR) RNA was extracted from leukocytes using the PAXgene 96 Blood RNA kit (PreAnalytiX, Hombrechtikon, Switzerland) according to the manufacturer's instructions. RNA concentration was determined by NanoDrop (NanoDrop Technologies, Wilmington, DE, USA), and random samples were inspected for RNA integrity using a Bioanalyzer (Agilent Technologies, Waldbronn, Germany). Two-hourly samples from 12:00 h on day 2 to 12:00 h on day 4 (25 samples per subject) were used for cDNA synthesis using the RevertAid TM H Minus First Strand cDNA synthesis kit (Fermentas, St. Leon-Rot, Germany) with random hexamer primers as described in the manufacturer's instructions.
cDNA was subjected to qRT-PCR using the LightCycler 480 SYBR Green I Kit on a
LightCycler 480 II platform (Roche Diagnostics, Mannheim, Germany). The protocol was as follows: 10 min at 95°C, 45 cycles of 95°C, 60°C, and 72°C (10 s each), followed by a melting curve step with continuous acquisition from 65 -97°C. Relative quantification of gene expression was performed using the second derivative maximum method (Roche Diagnostics) followed by the delta-delta-cycle-threshold (2 CT ) method as described (Ackermann et al., 2007) .
Five reference genes (GAPDH, ACTB, HPRT, PPIB, UBC) were tested for suitability using
NormFinder software (MOMA, Aarhus University Hospital, Aarhus, Denmark) to determine gene stability values and single cosinor analysis (Minors & Waterhouse, 1989) All primers were acquired from Metabion (Metabion, Martinsried, Germany) and tested for efficiency and specificity of amplification. Except for the HSPA1B gene, which does not contain introns, primers were designed to span at least one exon-exon junction using Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/), or were taken from published literature (Archer et al., 2008; Kimura et al., 2011; Lavebratt et al., 2010; Visser et al., 2011; Wu et al., 2006) , and were checked for transcript specificity using the UCSC In-silico PCR tool (http://genome.ucsc.edu/). Primer sequences are given in Supplementary Table S1 .
Data analysis:
Dim light melatonin onset (DLMO) was used as a marker of circadian timing and calculated for each individual for both the sleep (night 2, N2) and sleep deprivation (night 3, N3) nights using the 25%-threshold method as previously described (Sletten et al., 2009 ). Melatonin and cortisol profiles for each individual were subjected to cosinor analysis (Minors & Waterhouse, 1989 ) for determination of amplitude and peak time (acrophase) for the sleep and sleep deprivation conditions separately and for the collapsed data (full 48 hours of sampling period). Paired Student's t-tests (two-tailed) were performed to compare melatonin and cortisol rhythm parameters during sleep (N2) and sleep deprivation (N3) (DLMO, melatonin and cortisol acrophase and amplitude, and melatonin area under the curve (AUC)
with a 12 h night-time bin with individual acrophase as midpoint and a 6 h daytime bin as control) (GraphPad Prism 5).
Relative gene expression profiles for each individual were z-scored and subjected to cosinor analysis (Minors & Waterhouse, 1989 ) with a 24 h period (for HSPA1B additional analysis with a 12 h period was performed, as reported previously in mice (Hughes et al., 2009 )) for determination of peak time, amplitude, and significance of fit. Cosinor analysis was performed separately for each condition and the collapsed dataset as described for the hormone analysis. Calculated acrophases for melatonin and PER3 expression on N2 were subjected to Spearman correlation. Non-linear curve fitting using a cosine function with a 24 h period on z-scored normalised gene expression levels was employed to characterise diurnal rhythms for each gene (nls function of the stats package of R software version 2.12.0) as described recently (Ackermann et al., 2012) . This analysis was phase-adjusted individually using i) average melatonin peak time and ii) average DLMO on baseline sleep night (N2)
(two of the 12 participants exhibited a phase-delay in peak melatonin timing compared to the other subjects and were excluded for calculation of average peak time and DLMO). Gene expression data were phase-adjusted using the calculated time difference between individual melatonin peak time/DLMO and average melatonin peak time/DLMO for all downstream analysis. Equation for non-linear curve fitting: phase-adjusted normalised z-score =  i + *cos(2**(TP-t)/24); where TP is the sampling time,  i is the individual term for the individual i,  is the amplitude and t the peak time of the cosine function.
The following null hypotheses were tested for significance: 1) the amplitude and 2) peak times were not different from zero. Analysis was performed separately for the sleep and sleep deprivation condition, and for the collapsed 48 h dataset. The level of significance was reduced from p < .05 to p < .0042 (Bonferroni correction for multiple testing).
Results
Hormone rhythms
Cortisol
Individual cortisol profiles exhibited a significant (p < .03) diurnal pattern with peak times in the early morning (Supplementary Figure S1 ; Supplementary Table S2 ). There were no significant differences between the sleep and the sleep deprivation condition for either acrophase (p = .4913) or amplitude (p = .1040) (Figure 2 ).
Melatonin
Individual melatonin profiles showed a significant (p < .0001) diurnally rhythmic pattern with peak times in the second half of the night (Supplementary Figure S2 ; Supplementary Table S3 ). Compared to the sleep condition, during sleep deprivation, the melatonin acrophase was significantly delayed (mean ± SEM: 00.42 ± 00.14 h; p = .0129; Figure 2 Figure S4 ), but results showed a trend towards significance upon excluding the most phase-delayed subject ( Figure S2 ; p = 0.0572).
Gene expression levels
Diurnal rhythmicity in mRNA signatures during the baseline condition was found for most
but not all candidate genes tested. An illustration of individual profiles for each gene investigated is provided in Figure 3 , and a summary of the cosinor analysis is given in Table   1 . The most robust rhythms, displaying clear peaks and high amplitude, were detected for PER3 and REV-ERB, followed by BMAL1 and PER1. Eight out of the twelve subjects showed significant PER3 expression rhythms during the sleep condition (N2), and correlation with corresponding melatonin peak times showed a tendency towards significance (p = 0.069; n = 8). HSPA1B expression showed strong 24 h, but not 12 h, rhythmicity. Except for RORA
and DEC1, at least 3 out of the 12 subjects showed significant rhythmicity in expression levels for the 10 remaining genes, and the number of subjects with significant rhythms was found to be equal or lower during sleep deprivation compared to the sleep condition. Nonlinear curve fitting revealed significant rhythms in all genes, except DEC1 and CRY1/2, in at least one of the three conditions (sleep, sleep deprivation, collapsed 48 h) for data corrected to individual circadian time using both DLMO and melatonin peak time. Peak times calculated by non-linear curve fitting (Table 2, Supplementary Table S4 ) were in close agreement to the peak times determined using the cosinor method.
High-amplitude rhythms for all conditions (sleep, sleep deprivation, collapsed 48 h) were detected for PER1, PER3 and REV-ERB, while for BMAL1 and HSPA1 such high amplitudes were only found in the sleep condition. Closer examination revealed that the diurnal rhythms in expression levels of BMAL1 and HSPA1B were disrupted by sleep loss, exhibiting strongly reduced amplitudes (~70 % and ~50 % reduction for BMAL1 and HSPA1B, respectively) and loss of rhythmicity ( (Table 2 ). In addition, for CLOCK and DBP a strong reduction in amplitude during sleep deprivation was observed (~40% and ~18%, respectively; Table 2 ), even though rhythmicity was maintained.
In general, the amplitudes of the gene expression rhythms in the sleep deprivation condition were lower and less often reached statistical significance compared to the sleep condition.
Discussion
This study aimed to address the impact of one night of total sleep deprivation under controlled laboratory conditions on both biomarkers of the central circadian pacemaker and peripheral oscillators in blood cells.
Although melatonin is one of the best characterised and reliable markers of human circadian phase and widely used in sleep-related studies, there is surprisingly little conclusive information regarding the acute effects of sleep deprivation on the amplitude and timing of the melatonin rhythm (Salin-Pascual et al., 1988; von Treuer et al., 1996; Zeitzer et al., 2007) .
Our data are in agreement with the work of Salin-Pascual et al. (1988) which showed an increase in melatonin levels, but not in cortisol levels, during sleep deprivation, but in contrast with the study by von Treuer and colleagues (1996) which reported the opposite effects. Further in agreement with the current data, a phase delay in the melatonin rhythm has previously been reported after one night of sleep deprivation (Cajochen et al., 2003) , and an increase in melatonin levels was found in young subjects during extended wakefulness (up to 50 h) (Zeitzer et al., 2007) . The latter study, however, also described an age-dependent difference in melatonin profiles, with young subjects exhibiting reduced and older subjects exhibiting elevated melatonin levels during one night of sleep deprivation compared to habitual sleep.
While melatonin peak times were consistently delayed during sleep deprivation in all but the two phase-delayed subjects, the DLMO did not consistently change to later times on the sleep deprivation night (N3). This finding was predicted as we would not expect the DLMO to show the same change as the melatonin acrophase as in the early evening at DLMO the subjects were not yet sleep deprived and thus DLMO should be the same on both nights (N2 and N3). While the current melatonin data showed both, an increase and a phase-delay during sleep deprivation, similar changes in cortisol levels were not observed. . Even though we cannot fully exclude that the differential responses of melatonin and cortisol to sleep deprivation observed in our study are protocol-related, we hypothesise that the increase in melatonin might be interpreted as a direct consequence of the oxidative stress induced by sleep loss, and thus might be related to melatonin's well-reported antioxidative properties (Reiter et al., 2000) .
To support our hypothesis on the upregulation of melatonin, the heat shock gene HSPA1B was investigated as a representative of genes involved in the oxidative stress response.
Notably, expression of HSPA1B did not show 12 h rhythmicity, as previously reported for mouse tissues (Hughes et al., 2009 ), but instead strong 24 h rhythmicity during the sleep condition. The observed induction of HSPA1B during sleep deprivation is in agreement with previous work demonstrating its upregulation in obstructive sleep apnoea and diseaseassociated oxidative stress, and enhanced HSPA1B gene expression in several brain regions in mice during sleep deprivation (Lavie et al., 2010; Terao et al., 2003) . Interestingly, a recent study on changes in the brain transcriptome upon sleep deprivation demonstrated that upregulation of HSPA1B in mice remains even if the corticosterone arm of the stress response has been eliminated (Mongrain et al., 2010 (Ackermann et al., 2012) . Together, our data support the view that sleep deprivation can be regarded as a strong external stressor and immune challenge (Faraut et al., 2012; Mullington et al., 2010) .
The clock gene expression data collected in our study are in agreement with previous reports concerning the timing of clock gene rhythms in a regulate sleep/wake cycle and the proportion of individual significant rhythms for a given gene (see e.g. Archer et al., 2008) .
Our current data, including the in-depth characterization of the expression levels of 11 clock genes during normal sleep-wake and under sleep deprivation conditions, suggest that the core clock mechanism in peripheral oscillators is compromised under sleep deprivation conditions, as clock gene amplitudes were generally found to be lower compared to the sleep condition.
Strongest effects of condition (sleep, sleep deprivation) were found for the expression of BMAL1, and to a lesser extent, CRY1, both considered core clock components (Hastings et al., 2003) , which were acutely suppressed during sleep deprivation. Notably, other highamplitude clock gene rhythms (e.g. PER1, PER3, REV-ERB) remained unaffected by sleep deprivation. Our results are in agreement with a study describing diurnal variation of BMAL1 both under a normal sleep-wake schedule and a night of acute sleep deprivation in light conditions (50 lux) (Kavcic et al., 2011) . However, in this study a significant diurnal variation in PER2 was also reported in the sleep condition, while we found overall rhythmicity for PER1 and PER3, but not for PER2, under both sleep and sleep deprivation conditions. By contrast, James et al. (2007) reported comparable 24 h rhythmicity for both PER1 and PER2 under sleep/wake and constant routine sleep deprivation conditions, which is in line with our data on PER1 and PER3 . However, in contrast to the current results, a change in BMAL1 peak expression was observed between sleep deprivation and habitual sleep , whereas the current study showed no change in BMAL1 peak time but in amplitude. It should be noted that the sampling intervals chosen for the current study (from 12:00 h on day 2 to 12:00 h on day 4 after the sleep deprivation) must be considered a limitation as it might not have revealed the full effect of the sleep deprivation.
Taken together, our data show that one night of sleep deprivation has a significant impact on both the melatonin profile and the rhythmic expression of certain clock genes in human peripheral leukocytes. Further studies are needed for a better mechanistic understanding of the interactions between sleep deprivation, the circadian system, and the potential impact on immunity. Calculations for individual phase-adjustment were performed using the average melatonin peak time on the baseline sleep night (N2). Bold numbers indicate significance after Bonferroni correction for multiple testing (p < .0042). 
Tables
Supplementary
